nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4B—coronary artery disease	0.59	1	CbGaD
Flavoxate—PDE8A—cardiac ventricle—coronary artery disease	0.00202	0.111	CbGeAlD
Flavoxate—PDE8A—myocardium—coronary artery disease	0.0019	0.104	CbGeAlD
Flavoxate—PDE7B—heart—coronary artery disease	0.00185	0.101	CbGeAlD
Flavoxate—PDE8B—heart—coronary artery disease	0.00147	0.0808	CbGeAlD
Flavoxate—Raloxifene—ESR2—coronary artery disease	0.00146	0.473	CrCbGaD
Flavoxate—PDE8A—heart—coronary artery disease	0.00133	0.0727	CbGeAlD
Flavoxate—PDE4D—heart—coronary artery disease	0.0012	0.0658	CbGeAlD
Flavoxate—PDE8A—cardiac atrium—coronary artery disease	0.00113	0.0621	CbGeAlD
Flavoxate—PDE4A—heart—coronary artery disease	0.00106	0.0583	CbGeAlD
Flavoxate—PDE8A—blood—coronary artery disease	0.00099	0.0542	CbGeAlD
Flavoxate—PDE4B—cardiac ventricle—coronary artery disease	0.000966	0.0529	CbGeAlD
Flavoxate—PDE4B—myocardium—coronary artery disease	0.000909	0.0498	CbGeAlD
Flavoxate—Raloxifene—ESR1—coronary artery disease	0.000902	0.292	CrCbGaD
Flavoxate—Antrafenine—PTGS2—coronary artery disease	0.000727	0.235	CrCbGaD
Flavoxate—Eosinophilia—Ramipril—coronary artery disease	0.000696	0.00407	CcSEcCtD
Flavoxate—Urticaria—Gemfibrozil—coronary artery disease	0.000696	0.00407	CcSEcCtD
Flavoxate—Palpitations—Ezetimibe—coronary artery disease	0.000693	0.00406	CcSEcCtD
Flavoxate—Dry mouth—Fenofibrate—coronary artery disease	0.000682	0.00399	CcSEcCtD
Flavoxate—Tension—Niacin—coronary artery disease	0.000674	0.00394	CcSEcCtD
Flavoxate—Vertigo—Simvastatin—coronary artery disease	0.000672	0.00393	CcSEcCtD
Flavoxate—Leukopenia—Simvastatin—coronary artery disease	0.00067	0.00392	CcSEcCtD
Flavoxate—Nervousness—Niacin—coronary artery disease	0.000667	0.0039	CcSEcCtD
Flavoxate—Dry mouth—Lovastatin—coronary artery disease	0.000666	0.0039	CcSEcCtD
Flavoxate—Vision blurred—Valsartan—coronary artery disease	0.000666	0.0039	CcSEcCtD
Flavoxate—Somnolence—Acetylsalicylic acid—coronary artery disease	0.000665	0.00389	CcSEcCtD
Flavoxate—Tension—Pravastatin—coronary artery disease	0.000664	0.00388	CcSEcCtD
Flavoxate—Vision blurred—Olmesartan—coronary artery disease	0.000663	0.00388	CcSEcCtD
Flavoxate—Confusional state—Clopidogrel—coronary artery disease	0.000663	0.00388	CcSEcCtD
Flavoxate—Confusional state—Lovastatin—coronary artery disease	0.000658	0.00385	CcSEcCtD
Flavoxate—Nervousness—Pravastatin—coronary artery disease	0.000657	0.00384	CcSEcCtD
Flavoxate—Dry mouth—Ezetimibe—coronary artery disease	0.000653	0.00382	CcSEcCtD
Flavoxate—Tachycardia—Fenofibrate—coronary artery disease	0.000652	0.00382	CcSEcCtD
Flavoxate—Skin disorder—Fenofibrate—coronary artery disease	0.000649	0.0038	CcSEcCtD
Flavoxate—Vision blurred—Niacin—coronary artery disease	0.000647	0.00379	CcSEcCtD
Flavoxate—Confusional state—Ezetimibe—coronary artery disease	0.000646	0.00378	CcSEcCtD
Flavoxate—Headache—Penbutolol—coronary artery disease	0.000643	0.00376	CcSEcCtD
Flavoxate—Tension—Enalapril—coronary artery disease	0.000642	0.00376	CcSEcCtD
Flavoxate—Skin disorder—Clopidogrel—coronary artery disease	0.000638	0.00373	CcSEcCtD
Flavoxate—Vision blurred—Pravastatin—coronary artery disease	0.000637	0.00373	CcSEcCtD
Flavoxate—Nervousness—Enalapril—coronary artery disease	0.000635	0.00372	CcSEcCtD
Flavoxate—Vertigo—Valsartan—coronary artery disease	0.000635	0.00371	CcSEcCtD
Flavoxate—Feeling abnormal—Rosuvastatin—coronary artery disease	0.000635	0.00371	CcSEcCtD
Flavoxate—PDE4B—heart—coronary artery disease	0.000634	0.0347	CbGeAlD
Flavoxate—Tension—Telmisartan—coronary artery disease	0.000633	0.0037	CcSEcCtD
Flavoxate—Vertigo—Olmesartan—coronary artery disease	0.000632	0.0037	CcSEcCtD
Flavoxate—Eosinophilia—Lisinopril—coronary artery disease	0.000631	0.00369	CcSEcCtD
Flavoxate—CHRM2—heart—coronary artery disease	0.00063	0.0345	CbGeAlD
Flavoxate—Leukopenia—Olmesartan—coronary artery disease	0.000629	0.00368	CcSEcCtD
Flavoxate—Nervousness—Telmisartan—coronary artery disease	0.000627	0.00367	CcSEcCtD
Flavoxate—Palpitations—Valsartan—coronary artery disease	0.000624	0.00365	CcSEcCtD
Flavoxate—Skin disorder—Ezetimibe—coronary artery disease	0.000622	0.00364	CcSEcCtD
Flavoxate—Palpitations—Olmesartan—coronary artery disease	0.000621	0.00364	CcSEcCtD
Flavoxate—Vertigo—Niacin—coronary artery disease	0.000617	0.00361	CcSEcCtD
Flavoxate—Feeling abnormal—Acetylsalicylic acid—coronary artery disease	0.000617	0.00361	CcSEcCtD
Flavoxate—Vision blurred—Enalapril—coronary artery disease	0.000617	0.00361	CcSEcCtD
Flavoxate—Tension—Captopril—coronary artery disease	0.000616	0.0036	CcSEcCtD
Flavoxate—Confusional state—Simvastatin—coronary artery disease	0.000616	0.0036	CcSEcCtD
Flavoxate—Leukopenia—Niacin—coronary artery disease	0.000615	0.0036	CcSEcCtD
Flavoxate—Urticaria—Rosuvastatin—coronary artery disease	0.000612	0.00358	CcSEcCtD
Flavoxate—Nausea—Penbutolol—coronary artery disease	0.00061	0.00357	CcSEcCtD
Flavoxate—Nervousness—Captopril—coronary artery disease	0.000609	0.00357	CcSEcCtD
Flavoxate—Skin disorder—Eplerenone—coronary artery disease	0.000609	0.00356	CcSEcCtD
Flavoxate—Vertigo—Pravastatin—coronary artery disease	0.000608	0.00356	CcSEcCtD
Flavoxate—Palpitations—Niacin—coronary artery disease	0.000607	0.00355	CcSEcCtD
Flavoxate—Leukopenia—Pravastatin—coronary artery disease	0.000605	0.00354	CcSEcCtD
Flavoxate—Tension—Perindopril—coronary artery disease	0.000598	0.0035	CcSEcCtD
Flavoxate—Urticaria—Acetylsalicylic acid—coronary artery disease	0.000594	0.00348	CcSEcCtD
Flavoxate—CHRM2—cardiovascular system—coronary artery disease	0.000594	0.0326	CbGeAlD
Flavoxate—Somnolence—Fenofibrate—coronary artery disease	0.000594	0.00348	CcSEcCtD
Flavoxate—Nervousness—Perindopril—coronary artery disease	0.000592	0.00346	CcSEcCtD
Flavoxate—Vision blurred—Captopril—coronary artery disease	0.000591	0.00346	CcSEcCtD
Flavoxate—Vertigo—Trandolapril—coronary artery disease	0.00059	0.00345	CcSEcCtD
Flavoxate—Dry mouth—Valsartan—coronary artery disease	0.000588	0.00344	CcSEcCtD
Flavoxate—Leukopenia—Trandolapril—coronary artery disease	0.000588	0.00344	CcSEcCtD
Flavoxate—Vertigo—Enalapril—coronary artery disease	0.000588	0.00344	CcSEcCtD
Flavoxate—Leukopenia—Enalapril—coronary artery disease	0.000586	0.00343	CcSEcCtD
Flavoxate—Palpitations—Trandolapril—coronary artery disease	0.00058	0.0034	CcSEcCtD
Flavoxate—Vertigo—Telmisartan—coronary artery disease	0.00058	0.00339	CcSEcCtD
Flavoxate—Palpitations—Enalapril—coronary artery disease	0.000578	0.00338	CcSEcCtD
Flavoxate—Dry mouth—Niacin—coronary artery disease	0.000572	0.00335	CcSEcCtD
Flavoxate—Palpitations—Telmisartan—coronary artery disease	0.00057	0.00334	CcSEcCtD
Flavoxate—Tension—Losartan—coronary artery disease	0.000561	0.00328	CcSEcCtD
Flavoxate—Skin disorder—Valsartan—coronary artery disease	0.00056	0.00328	CcSEcCtD
Flavoxate—Tachycardia—Olmesartan—coronary artery disease	0.00056	0.00328	CcSEcCtD
Flavoxate—Vision blurred—Furosemide—coronary artery disease	0.000558	0.00327	CcSEcCtD
Flavoxate—Skin disorder—Olmesartan—coronary artery disease	0.000557	0.00326	CcSEcCtD
Flavoxate—Vomiting—Gemfibrozil—coronary artery disease	0.000557	0.00326	CcSEcCtD
Flavoxate—Confusional state—Pravastatin—coronary artery disease	0.000557	0.00326	CcSEcCtD
Flavoxate—Nervousness—Losartan—coronary artery disease	0.000555	0.00325	CcSEcCtD
Flavoxate—Palpitations—Captopril—coronary artery disease	0.000554	0.00324	CcSEcCtD
Flavoxate—Feeling abnormal—Fenofibrate—coronary artery disease	0.000551	0.00322	CcSEcCtD
Flavoxate—Headache—Gemfibrozil—coronary artery disease	0.000549	0.00321	CcSEcCtD
Flavoxate—Vertigo—Perindopril—coronary artery disease	0.000547	0.0032	CcSEcCtD
Flavoxate—Tachycardia—Niacin—coronary artery disease	0.000547	0.0032	CcSEcCtD
Flavoxate—Dry mouth—Trandolapril—coronary artery disease	0.000547	0.0032	CcSEcCtD
Flavoxate—Leukopenia—Perindopril—coronary artery disease	0.000545	0.00319	CcSEcCtD
Flavoxate—Dry mouth—Enalapril—coronary artery disease	0.000545	0.00319	CcSEcCtD
Flavoxate—Skin disorder—Niacin—coronary artery disease	0.000545	0.00319	CcSEcCtD
Flavoxate—Vomiting—Ticagrelor—coronary artery disease	0.000544	0.00318	CcSEcCtD
Flavoxate—PDE4B—cardiac atrium—coronary artery disease	0.000542	0.0297	CbGeAlD
Flavoxate—Feeling abnormal—Clopidogrel—coronary artery disease	0.000542	0.00317	CcSEcCtD
Flavoxate—CHRM1—cardiovascular system—coronary artery disease	0.000541	0.0296	CbGeAlD
Flavoxate—Vision blurred—Losartan—coronary artery disease	0.000538	0.00315	CcSEcCtD
Flavoxate—Palpitations—Perindopril—coronary artery disease	0.000538	0.00315	CcSEcCtD
Flavoxate—Confusional state—Enalapril—coronary artery disease	0.000538	0.00315	CcSEcCtD
Flavoxate—Feeling abnormal—Lovastatin—coronary artery disease	0.000538	0.00315	CcSEcCtD
Flavoxate—Dry mouth—Telmisartan—coronary artery disease	0.000537	0.00314	CcSEcCtD
Flavoxate—Headache—Ticagrelor—coronary artery disease	0.000536	0.00314	CcSEcCtD
Flavoxate—Vertigo—Furosemide—coronary artery disease	0.000532	0.00311	CcSEcCtD
Flavoxate—Urticaria—Fenofibrate—coronary artery disease	0.000531	0.00311	CcSEcCtD
Flavoxate—Leukopenia—Furosemide—coronary artery disease	0.00053	0.0031	CcSEcCtD
Flavoxate—Feeling abnormal—Ezetimibe—coronary artery disease	0.000528	0.00309	CcSEcCtD
Flavoxate—Tachycardia—Trandolapril—coronary artery disease	0.000523	0.00306	CcSEcCtD
Flavoxate—Dry mouth—Captopril—coronary artery disease	0.000522	0.00306	CcSEcCtD
Flavoxate—Urticaria—Clopidogrel—coronary artery disease	0.000522	0.00305	CcSEcCtD
Flavoxate—Tachycardia—Enalapril—coronary artery disease	0.000521	0.00305	CcSEcCtD
Flavoxate—Skin disorder—Trandolapril—coronary artery disease	0.000521	0.00305	CcSEcCtD
Flavoxate—Nausea—Gemfibrozil—coronary artery disease	0.00052	0.00304	CcSEcCtD
Flavoxate—Urticaria—Lovastatin—coronary artery disease	0.000519	0.00303	CcSEcCtD
Flavoxate—Feeling abnormal—Eplerenone—coronary artery disease	0.000516	0.00302	CcSEcCtD
Flavoxate—Confusional state—Captopril—coronary artery disease	0.000516	0.00302	CcSEcCtD
Flavoxate—Tachycardia—Telmisartan—coronary artery disease	0.000514	0.00301	CcSEcCtD
Flavoxate—Vertigo—Losartan—coronary artery disease	0.000513	0.003	CcSEcCtD
Flavoxate—Somnolence—Valsartan—coronary artery disease	0.000513	0.003	CcSEcCtD
Flavoxate—Skin disorder—Telmisartan—coronary artery disease	0.000511	0.00299	CcSEcCtD
Flavoxate—Leukopenia—Losartan—coronary artery disease	0.000511	0.00299	CcSEcCtD
Flavoxate—Urticaria—Ezetimibe—coronary artery disease	0.000509	0.00298	CcSEcCtD
Flavoxate—Nausea—Ticagrelor—coronary artery disease	0.000508	0.00297	CcSEcCtD
Flavoxate—Dry mouth—Perindopril—coronary artery disease	0.000507	0.00297	CcSEcCtD
Flavoxate—Palpitations—Losartan—coronary artery disease	0.000505	0.00295	CcSEcCtD
Flavoxate—Feeling abnormal—Simvastatin—coronary artery disease	0.000503	0.00294	CcSEcCtD
Flavoxate—Confusional state—Perindopril—coronary artery disease	0.000501	0.00293	CcSEcCtD
Flavoxate—Tachycardia—Captopril—coronary artery disease	0.0005	0.00292	CcSEcCtD
Flavoxate—Somnolence—Niacin—coronary artery disease	0.000498	0.00292	CcSEcCtD
Flavoxate—Dry mouth—Furosemide—coronary artery disease	0.000493	0.00289	CcSEcCtD
Flavoxate—Confusional state—Furosemide—coronary artery disease	0.000487	0.00285	CcSEcCtD
Flavoxate—Tachycardia—Perindopril—coronary artery disease	0.000485	0.00284	CcSEcCtD
Flavoxate—Urticaria—Simvastatin—coronary artery disease	0.000485	0.00284	CcSEcCtD
Flavoxate—Skin disorder—Perindopril—coronary artery disease	0.000483	0.00283	CcSEcCtD
Flavoxate—Headache—Rosuvastatin—coronary artery disease	0.000483	0.00282	CcSEcCtD
Flavoxate—Tension—Ramipril—coronary artery disease	0.000481	0.00281	CcSEcCtD
Flavoxate—Somnolence—Trandolapril—coronary artery disease	0.000477	0.00279	CcSEcCtD
Flavoxate—Nervousness—Ramipril—coronary artery disease	0.000476	0.00278	CcSEcCtD
Flavoxate—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000476	0.00278	CcSEcCtD
Flavoxate—Dry mouth—Losartan—coronary artery disease	0.000476	0.00278	CcSEcCtD
Flavoxate—Somnolence—Enalapril—coronary artery disease	0.000475	0.00278	CcSEcCtD
Flavoxate—PDE4B—blood—coronary artery disease	0.000473	0.0259	CbGeAlD
Flavoxate—Feeling abnormal—Olmesartan—coronary artery disease	0.000473	0.00277	CcSEcCtD
Flavoxate—Confusional state—Losartan—coronary artery disease	0.00047	0.00275	CcSEcCtD
Flavoxate—Tension—Timolol—coronary artery disease	0.00047	0.00275	CcSEcCtD
Flavoxate—Skin disorder—Furosemide—coronary artery disease	0.000469	0.00275	CcSEcCtD
Flavoxate—Somnolence—Telmisartan—coronary artery disease	0.000468	0.00274	CcSEcCtD
Flavoxate—Nervousness—Timolol—coronary artery disease	0.000465	0.00272	CcSEcCtD
Flavoxate—Urticaria—Valsartan—coronary artery disease	0.000458	0.00268	CcSEcCtD
Flavoxate—Nausea—Rosuvastatin—coronary artery disease	0.000458	0.00268	CcSEcCtD
Flavoxate—Urticaria—Olmesartan—coronary artery disease	0.000456	0.00267	CcSEcCtD
Flavoxate—Somnolence—Captopril—coronary artery disease	0.000455	0.00266	CcSEcCtD
Flavoxate—Tachycardia—Losartan—coronary artery disease	0.000455	0.00266	CcSEcCtD
Flavoxate—Feeling abnormal—Pravastatin—coronary artery disease	0.000455	0.00266	CcSEcCtD
Flavoxate—Vision blurred—Timolol—coronary artery disease	0.000451	0.00264	CcSEcCtD
Flavoxate—Urticaria—Niacin—coronary artery disease	0.000445	0.00261	CcSEcCtD
Flavoxate—Nausea—Acetylsalicylic acid—coronary artery disease	0.000444	0.0026	CcSEcCtD
Flavoxate—Somnolence—Perindopril—coronary artery disease	0.000442	0.00259	CcSEcCtD
Flavoxate—Feeling abnormal—Trandolapril—coronary artery disease	0.000442	0.00258	CcSEcCtD
Flavoxate—Vertigo—Ramipril—coronary artery disease	0.00044	0.00258	CcSEcCtD
Flavoxate—Feeling abnormal—Enalapril—coronary artery disease	0.00044	0.00257	CcSEcCtD
Flavoxate—Leukopenia—Ramipril—coronary artery disease	0.000439	0.00257	CcSEcCtD
Flavoxate—Urticaria—Pravastatin—coronary artery disease	0.000439	0.00257	CcSEcCtD
Flavoxate—Tension—Lisinopril—coronary artery disease	0.000436	0.00255	CcSEcCtD
Flavoxate—Feeling abnormal—Telmisartan—coronary artery disease	0.000434	0.00254	CcSEcCtD
Flavoxate—Palpitations—Ramipril—coronary artery disease	0.000433	0.00253	CcSEcCtD
Flavoxate—Nervousness—Lisinopril—coronary artery disease	0.000432	0.00253	CcSEcCtD
Flavoxate—Vertigo—Timolol—coronary artery disease	0.00043	0.00252	CcSEcCtD
Flavoxate—Somnolence—Furosemide—coronary artery disease	0.00043	0.00251	CcSEcCtD
Flavoxate—Urticaria—Trandolapril—coronary artery disease	0.000426	0.00249	CcSEcCtD
Flavoxate—Vomiting—Fenofibrate—coronary artery disease	0.000425	0.00249	CcSEcCtD
Flavoxate—Urticaria—Enalapril—coronary artery disease	0.000424	0.00248	CcSEcCtD
Flavoxate—Palpitations—Timolol—coronary artery disease	0.000423	0.00248	CcSEcCtD
Flavoxate—Feeling abnormal—Captopril—coronary artery disease	0.000422	0.00247	CcSEcCtD
Flavoxate—Headache—Fenofibrate—coronary artery disease	0.000419	0.00245	CcSEcCtD
Flavoxate—Vision blurred—Lisinopril—coronary artery disease	0.000419	0.00245	CcSEcCtD
Flavoxate—Urticaria—Telmisartan—coronary artery disease	0.000418	0.00245	CcSEcCtD
Flavoxate—Vomiting—Clopidogrel—coronary artery disease	0.000418	0.00244	CcSEcCtD
Flavoxate—Vomiting—Lovastatin—coronary artery disease	0.000415	0.00243	CcSEcCtD
Flavoxate—Somnolence—Losartan—coronary artery disease	0.000415	0.00243	CcSEcCtD
Flavoxate—Headache—Clopidogrel—coronary artery disease	0.000412	0.00241	CcSEcCtD
Flavoxate—Feeling abnormal—Perindopril—coronary artery disease	0.00041	0.0024	CcSEcCtD
Flavoxate—Headache—Lovastatin—coronary artery disease	0.000409	0.00239	CcSEcCtD
Flavoxate—Dry mouth—Ramipril—coronary artery disease	0.000408	0.00239	CcSEcCtD
Flavoxate—Vomiting—Ezetimibe—coronary artery disease	0.000407	0.00238	CcSEcCtD
Flavoxate—Confusional state—Ramipril—coronary artery disease	0.000403	0.00236	CcSEcCtD
Flavoxate—Headache—Ezetimibe—coronary artery disease	0.000401	0.00235	CcSEcCtD
Flavoxate—Vertigo—Lisinopril—coronary artery disease	0.000399	0.00234	CcSEcCtD
Flavoxate—Dry mouth—Timolol—coronary artery disease	0.000399	0.00233	CcSEcCtD
Flavoxate—Vomiting—Eplerenone—coronary artery disease	0.000398	0.00233	CcSEcCtD
Flavoxate—Feeling abnormal—Furosemide—coronary artery disease	0.000398	0.00233	CcSEcCtD
Flavoxate—Leukopenia—Lisinopril—coronary artery disease	0.000398	0.00233	CcSEcCtD
Flavoxate—Nausea—Fenofibrate—coronary artery disease	0.000397	0.00232	CcSEcCtD
Flavoxate—Urticaria—Perindopril—coronary artery disease	0.000395	0.00231	CcSEcCtD
Flavoxate—Confusional state—Timolol—coronary artery disease	0.000394	0.00231	CcSEcCtD
Flavoxate—Palpitations—Lisinopril—coronary artery disease	0.000393	0.0023	CcSEcCtD
Flavoxate—Headache—Eplerenone—coronary artery disease	0.000393	0.0023	CcSEcCtD
Flavoxate—Nausea—Clopidogrel—coronary artery disease	0.00039	0.00228	CcSEcCtD
Flavoxate—Tachycardia—Ramipril—coronary artery disease	0.00039	0.00228	CcSEcCtD
Flavoxate—Skin disorder—Ramipril—coronary artery disease	0.000388	0.00227	CcSEcCtD
Flavoxate—Vomiting—Simvastatin—coronary artery disease	0.000388	0.00227	CcSEcCtD
Flavoxate—Nausea—Lovastatin—coronary artery disease	0.000388	0.00227	CcSEcCtD
Flavoxate—Feeling abnormal—Losartan—coronary artery disease	0.000384	0.00225	CcSEcCtD
Flavoxate—Urticaria—Furosemide—coronary artery disease	0.000384	0.00225	CcSEcCtD
Flavoxate—Headache—Simvastatin—coronary artery disease	0.000382	0.00224	CcSEcCtD
Flavoxate—Nausea—Ezetimibe—coronary artery disease	0.00038	0.00223	CcSEcCtD
Flavoxate—Skin disorder—Timolol—coronary artery disease	0.00038	0.00222	CcSEcCtD
Flavoxate—Nausea—Eplerenone—coronary artery disease	0.000372	0.00218	CcSEcCtD
Flavoxate—Urticaria—Losartan—coronary artery disease	0.00037	0.00217	CcSEcCtD
Flavoxate—Dry mouth—Lisinopril—coronary artery disease	0.00037	0.00216	CcSEcCtD
Flavoxate—Vomiting—Valsartan—coronary artery disease	0.000367	0.00215	CcSEcCtD
Flavoxate—Confusional state—Lisinopril—coronary artery disease	0.000366	0.00214	CcSEcCtD
Flavoxate—Vomiting—Olmesartan—coronary artery disease	0.000365	0.00213	CcSEcCtD
Flavoxate—Nausea—Simvastatin—coronary artery disease	0.000363	0.00212	CcSEcCtD
Flavoxate—Headache—Valsartan—coronary artery disease	0.000361	0.00211	CcSEcCtD
Flavoxate—Headache—Olmesartan—coronary artery disease	0.000359	0.0021	CcSEcCtD
Flavoxate—Vomiting—Niacin—coronary artery disease	0.000356	0.00209	CcSEcCtD
Flavoxate—Somnolence—Ramipril—coronary artery disease	0.000355	0.00208	CcSEcCtD
Flavoxate—Tachycardia—Lisinopril—coronary artery disease	0.000354	0.00207	CcSEcCtD
Flavoxate—Skin disorder—Lisinopril—coronary artery disease	0.000352	0.00206	CcSEcCtD
Flavoxate—Headache—Niacin—coronary artery disease	0.000351	0.00205	CcSEcCtD
Flavoxate—Vomiting—Pravastatin—coronary artery disease	0.000351	0.00205	CcSEcCtD
Flavoxate—Somnolence—Timolol—coronary artery disease	0.000348	0.00203	CcSEcCtD
Flavoxate—Headache—Pravastatin—coronary artery disease	0.000346	0.00202	CcSEcCtD
Flavoxate—Nausea—Valsartan—coronary artery disease	0.000342	0.002	CcSEcCtD
Flavoxate—Nausea—Olmesartan—coronary artery disease	0.000341	0.00199	CcSEcCtD
Flavoxate—Vomiting—Trandolapril—coronary artery disease	0.000341	0.00199	CcSEcCtD
Flavoxate—Vomiting—Enalapril—coronary artery disease	0.000339	0.00199	CcSEcCtD
Flavoxate—Headache—Trandolapril—coronary artery disease	0.000336	0.00196	CcSEcCtD
Flavoxate—Vomiting—Telmisartan—coronary artery disease	0.000335	0.00196	CcSEcCtD
Flavoxate—Headache—Enalapril—coronary artery disease	0.000334	0.00196	CcSEcCtD
Flavoxate—Nausea—Niacin—coronary artery disease	0.000333	0.00195	CcSEcCtD
Flavoxate—Headache—Telmisartan—coronary artery disease	0.00033	0.00193	CcSEcCtD
Flavoxate—Feeling abnormal—Ramipril—coronary artery disease	0.00033	0.00193	CcSEcCtD
Flavoxate—Nausea—Pravastatin—coronary artery disease	0.000328	0.00192	CcSEcCtD
Flavoxate—Vomiting—Captopril—coronary artery disease	0.000326	0.0019	CcSEcCtD
Flavoxate—Somnolence—Lisinopril—coronary artery disease	0.000322	0.00189	CcSEcCtD
Flavoxate—Feeling abnormal—Timolol—coronary artery disease	0.000322	0.00188	CcSEcCtD
Flavoxate—Headache—Captopril—coronary artery disease	0.000321	0.00188	CcSEcCtD
Flavoxate—Nausea—Trandolapril—coronary artery disease	0.000318	0.00186	CcSEcCtD
Flavoxate—Urticaria—Ramipril—coronary artery disease	0.000318	0.00186	CcSEcCtD
Flavoxate—Nausea—Enalapril—coronary artery disease	0.000317	0.00186	CcSEcCtD
Flavoxate—Vomiting—Perindopril—coronary artery disease	0.000316	0.00185	CcSEcCtD
Flavoxate—Nausea—Telmisartan—coronary artery disease	0.000313	0.00183	CcSEcCtD
Flavoxate—Headache—Perindopril—coronary artery disease	0.000311	0.00182	CcSEcCtD
Flavoxate—Urticaria—Timolol—coronary artery disease	0.000311	0.00182	CcSEcCtD
Flavoxate—Vomiting—Furosemide—coronary artery disease	0.000307	0.0018	CcSEcCtD
Flavoxate—Nausea—Captopril—coronary artery disease	0.000304	0.00178	CcSEcCtD
Flavoxate—Headache—Furosemide—coronary artery disease	0.000303	0.00177	CcSEcCtD
Flavoxate—Feeling abnormal—Lisinopril—coronary artery disease	0.000299	0.00175	CcSEcCtD
Flavoxate—Vomiting—Losartan—coronary artery disease	0.000296	0.00173	CcSEcCtD
Flavoxate—Nausea—Perindopril—coronary artery disease	0.000295	0.00173	CcSEcCtD
Flavoxate—Headache—Losartan—coronary artery disease	0.000292	0.00171	CcSEcCtD
Flavoxate—Urticaria—Lisinopril—coronary artery disease	0.000288	0.00169	CcSEcCtD
Flavoxate—Nausea—Furosemide—coronary artery disease	0.000287	0.00168	CcSEcCtD
Flavoxate—Nausea—Losartan—coronary artery disease	0.000277	0.00162	CcSEcCtD
Flavoxate—Vomiting—Ramipril—coronary artery disease	0.000254	0.00149	CcSEcCtD
Flavoxate—Headache—Ramipril—coronary artery disease	0.00025	0.00147	CcSEcCtD
Flavoxate—Vomiting—Timolol—coronary artery disease	0.000249	0.00145	CcSEcCtD
Flavoxate—Headache—Timolol—coronary artery disease	0.000245	0.00143	CcSEcCtD
Flavoxate—Nausea—Ramipril—coronary artery disease	0.000238	0.00139	CcSEcCtD
Flavoxate—Nausea—Timolol—coronary artery disease	0.000232	0.00136	CcSEcCtD
Flavoxate—Vomiting—Lisinopril—coronary artery disease	0.000231	0.00135	CcSEcCtD
Flavoxate—Headache—Lisinopril—coronary artery disease	0.000227	0.00133	CcSEcCtD
Flavoxate—Nausea—Lisinopril—coronary artery disease	0.000215	0.00126	CcSEcCtD
Flavoxate—PDE4A—Signaling Pathways—JAK2—coronary artery disease	8.26e-06	3.79e-05	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CA—coronary artery disease	8.25e-06	3.78e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—coronary artery disease	8.24e-06	3.78e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—coronary artery disease	8.23e-06	3.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGB—coronary artery disease	8.23e-06	3.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HTR2A—coronary artery disease	8.21e-06	3.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—C3—coronary artery disease	8.2e-06	3.76e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDNRB—coronary artery disease	8.15e-06	3.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGB—coronary artery disease	8.13e-06	3.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HTR2A—coronary artery disease	8.11e-06	3.72e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CA—coronary artery disease	8.1e-06	3.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—C3—coronary artery disease	8.1e-06	3.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDNRB—coronary artery disease	8.04e-06	3.69e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—THBS1—coronary artery disease	8.03e-06	3.68e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKT1—coronary artery disease	7.99e-06	3.66e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—FGF2—coronary artery disease	7.98e-06	3.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMB5—coronary artery disease	7.95e-06	3.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMA6—coronary artery disease	7.95e-06	3.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—F2—coronary artery disease	7.93e-06	3.63e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CXCL8—coronary artery disease	7.92e-06	3.63e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—THBS1—coronary artery disease	7.92e-06	3.63e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—NOS3—coronary artery disease	7.87e-06	3.61e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—coronary artery disease	7.85e-06	3.6e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMA6—coronary artery disease	7.85e-06	3.6e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMB5—coronary artery disease	7.85e-06	3.6e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—F2—coronary artery disease	7.83e-06	3.59e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AGT—coronary artery disease	7.79e-06	3.57e-05	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKT1—coronary artery disease	7.79e-06	3.57e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDNRA—coronary artery disease	7.69e-06	3.53e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AGT—coronary artery disease	7.69e-06	3.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CYBA—coronary artery disease	7.66e-06	3.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB1—coronary artery disease	7.66e-06	3.51e-05	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKT1—coronary artery disease	7.66e-06	3.51e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—JAK2—coronary artery disease	7.65e-06	3.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DUSP6—coronary artery disease	7.63e-06	3.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDNRA—coronary artery disease	7.6e-06	3.48e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CASP3—coronary artery disease	7.58e-06	3.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CYBA—coronary artery disease	7.56e-06	3.47e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB1—coronary artery disease	7.56e-06	3.47e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CXCL8—coronary artery disease	7.54e-06	3.46e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—coronary artery disease	7.54e-06	3.45e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DUSP6—coronary artery disease	7.53e-06	3.45e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLAT—coronary artery disease	7.5e-06	3.44e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CA—coronary artery disease	7.49e-06	3.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLAT—coronary artery disease	7.4e-06	3.39e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—coronary artery disease	7.39e-06	3.39e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCND1—coronary artery disease	7.38e-06	3.38e-05	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKT1—coronary artery disease	7.29e-06	3.34e-05	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKT1—coronary artery disease	7.24e-06	3.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL12—coronary artery disease	7.23e-06	3.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BDKRB2—coronary artery disease	7.23e-06	3.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—POMC—coronary artery disease	7.22e-06	3.31e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CASP3—coronary artery disease	7.22e-06	3.31e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—F2—coronary artery disease	7.2e-06	3.3e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—coronary artery disease	7.17e-06	3.29e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6ST—coronary artery disease	7.17e-06	3.29e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—coronary artery disease	7.17e-06	3.29e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BDKRB2—coronary artery disease	7.14e-06	3.27e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL12—coronary artery disease	7.14e-06	3.27e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—coronary artery disease	7.13e-06	3.27e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—F2—coronary artery disease	7.11e-06	3.26e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JUNB—coronary artery disease	7.1e-06	3.25e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6ST—coronary artery disease	7.08e-06	3.25e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLCB1—coronary artery disease	7.08e-06	3.24e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCND1—coronary artery disease	7.03e-06	3.22e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JUNB—coronary artery disease	7.01e-06	3.21e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	6.98e-06	3.2e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL8—coronary artery disease	6.98e-06	3.2e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT1—coronary artery disease	6.95e-06	3.19e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR7—coronary artery disease	6.93e-06	3.18e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR7—coronary artery disease	6.84e-06	3.13e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—coronary artery disease	6.82e-06	3.13e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—coronary artery disease	6.79e-06	3.11e-05	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT1—coronary artery disease	6.74e-06	3.09e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CASP3—coronary artery disease	6.68e-06	3.06e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK1—coronary artery disease	6.65e-06	3.05e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—coronary artery disease	6.64e-06	3.04e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT1—coronary artery disease	6.62e-06	3.03e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITGAV—coronary artery disease	6.6e-06	3.03e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KNG1—coronary artery disease	6.58e-06	3.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—coronary artery disease	6.56e-06	3.01e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CREB1—coronary artery disease	6.56e-06	3.01e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGTR1—coronary artery disease	6.54e-06	3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	6.52e-06	2.99e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCND1—coronary artery disease	6.5e-06	2.98e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KNG1—coronary artery disease	6.5e-06	2.98e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—coronary artery disease	6.48e-06	2.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	6.48e-06	2.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	6.46e-06	2.96e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—coronary artery disease	6.44e-06	2.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL2—coronary artery disease	6.42e-06	2.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6R—coronary artery disease	6.4e-06	2.93e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL10—coronary artery disease	6.39e-06	2.93e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLG—coronary artery disease	6.38e-06	2.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	6.34e-06	2.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	6.32e-06	2.9e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—coronary artery disease	6.31e-06	2.89e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	6.31e-06	2.89e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLG—coronary artery disease	6.29e-06	2.88e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—coronary artery disease	6.21e-06	2.85e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCE—coronary artery disease	6.13e-06	2.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	6.13e-06	2.81e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—coronary artery disease	6.13e-06	2.81e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT1—coronary artery disease	6.12e-06	2.81e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—JAK2—coronary artery disease	6.12e-06	2.81e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SOCS1—coronary artery disease	6.11e-06	2.8e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—S100B—coronary artery disease	6.1e-06	2.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	6.05e-06	2.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	6.04e-06	2.77e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SOCS3—coronary artery disease	6.04e-06	2.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	6.03e-06	2.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—S100B—coronary artery disease	6.02e-06	2.76e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KITLG—coronary artery disease	5.97e-06	2.73e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFBR2—coronary artery disease	5.97e-06	2.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	5.96e-06	2.73e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—coronary artery disease	5.91e-06	2.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KITLG—coronary artery disease	5.89e-06	2.7e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	5.89e-06	2.7e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT5A—coronary artery disease	5.83e-06	2.67e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP3—coronary artery disease	5.83e-06	2.67e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK1—coronary artery disease	5.79e-06	2.66e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CA—coronary artery disease	5.77e-06	2.65e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP3—coronary artery disease	5.76e-06	2.64e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	5.76e-06	2.64e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—coronary artery disease	5.67e-06	2.6e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOB—coronary artery disease	5.64e-06	2.58e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—coronary artery disease	5.62e-06	2.58e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL8—coronary artery disease	5.59e-06	2.56e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOB—coronary artery disease	5.56e-06	2.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—JAK2—coronary artery disease	5.56e-06	2.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDN1—coronary artery disease	5.55e-06	2.54e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	5.52e-06	2.53e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK1—coronary artery disease	5.51e-06	2.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL5—coronary artery disease	5.5e-06	2.52e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	5.49e-06	2.52e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDN1—coronary artery disease	5.48e-06	2.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL5—coronary artery disease	5.43e-06	2.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CSF2—coronary artery disease	5.42e-06	2.48e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGF1—coronary artery disease	5.42e-06	2.48e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LPL—coronary artery disease	5.38e-06	2.47e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGF1—coronary artery disease	5.35e-06	2.45e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CSF2—coronary artery disease	5.35e-06	2.45e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RPS6KB1—coronary artery disease	5.33e-06	2.44e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MEF2C—coronary artery disease	5.33e-06	2.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LPL—coronary artery disease	5.31e-06	2.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	5.26e-06	2.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	5.26e-06	2.41e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—coronary artery disease	5.2e-06	2.38e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITGB3—coronary artery disease	5.2e-06	2.38e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	5.13e-06	2.35e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—coronary artery disease	5.11e-06	2.34e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK1—coronary artery disease	5.1e-06	2.34e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL8—coronary artery disease	5.07e-06	2.33e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PPP2CA—coronary artery disease	5.05e-06	2.31e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CA—coronary artery disease	5.03e-06	2.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	5.01e-06	2.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	4.98e-06	2.28e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCD—coronary artery disease	4.96e-06	2.27e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	4.89e-06	2.24e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—coronary artery disease	4.85e-06	2.22e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—C3—coronary artery disease	4.85e-06	2.22e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	4.79e-06	2.2e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CA—coronary artery disease	4.78e-06	2.19e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—C3—coronary artery disease	4.78e-06	2.19e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT1—coronary artery disease	4.72e-06	2.16e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HIF1A—coronary artery disease	4.62e-06	2.12e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGT—coronary artery disease	4.6e-06	2.11e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	4.56e-06	2.09e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGT—coronary artery disease	4.54e-06	2.08e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—coronary artery disease	4.51e-06	2.07e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOE—coronary artery disease	4.51e-06	2.07e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOA1—coronary artery disease	4.46e-06	2.04e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOE—coronary artery disease	4.45e-06	2.04e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—coronary artery disease	4.45e-06	2.04e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—coronary artery disease	4.45e-06	2.04e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CA—coronary artery disease	4.43e-06	2.03e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KDR—coronary artery disease	4.42e-06	2.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOA1—coronary artery disease	4.4e-06	2.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK14—coronary artery disease	4.39e-06	2.01e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KDR—coronary artery disease	4.36e-06	2e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	4.33e-06	1.99e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ESR1—coronary artery disease	4.31e-06	1.97e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—F2—coronary artery disease	4.25e-06	1.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FN1—coronary artery disease	4.25e-06	1.95e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ESR1—coronary artery disease	4.25e-06	1.95e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—coronary artery disease	4.24e-06	1.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6ST—coronary artery disease	4.24e-06	1.94e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NFKBIA—coronary artery disease	4.2e-06	1.93e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FN1—coronary artery disease	4.2e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—F2—coronary artery disease	4.2e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	4.18e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	4.15e-06	1.9e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT1—coronary artery disease	4.11e-06	1.88e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KIT—coronary artery disease	4.07e-06	1.87e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KIT—coronary artery disease	4.02e-06	1.84e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—coronary artery disease	3.92e-06	1.8e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT1—coronary artery disease	3.91e-06	1.79e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GSK3B—coronary artery disease	3.91e-06	1.79e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—coronary artery disease	3.87e-06	1.78e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CREB1—coronary artery disease	3.87e-06	1.78e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	3.86e-06	1.77e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—coronary artery disease	3.83e-06	1.75e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CREB1—coronary artery disease	3.83e-06	1.75e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL2—coronary artery disease	3.79e-06	1.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6R—coronary artery disease	3.78e-06	1.73e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL2—coronary artery disease	3.74e-06	1.72e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6R—coronary artery disease	3.73e-06	1.71e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—coronary artery disease	3.73e-06	1.71e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—MAPK1—coronary artery disease	3.71e-06	1.7e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—coronary artery disease	3.68e-06	1.69e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	3.66e-06	1.68e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT1—coronary artery disease	3.62e-06	1.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CA—coronary artery disease	3.54e-06	1.62e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—coronary artery disease	3.54e-06	1.62e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	3.5e-06	1.6e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	3.49e-06	1.6e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGF2—coronary artery disease	3.43e-06	1.57e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGF2—coronary artery disease	3.38e-06	1.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—coronary artery disease	3.38e-06	1.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—coronary artery disease	3.34e-06	1.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JAK2—coronary artery disease	3.28e-06	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JAK2—coronary artery disease	3.24e-06	1.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CA—coronary artery disease	3.22e-06	1.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	3.18e-06	1.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL8—coronary artery disease	3e-06	1.37e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	2.96e-06	1.36e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT1—coronary artery disease	2.9e-06	1.33e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CASP3—coronary artery disease	2.87e-06	1.32e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	2.86e-06	1.31e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—coronary artery disease	2.85e-06	1.31e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CASP3—coronary artery disease	2.83e-06	1.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—coronary artery disease	2.81e-06	1.29e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCND1—coronary artery disease	2.79e-06	1.28e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCND1—coronary artery disease	2.76e-06	1.26e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—coronary artery disease	2.71e-06	1.24e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—coronary artery disease	2.68e-06	1.23e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT1—coronary artery disease	2.63e-06	1.21e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	2.6e-06	1.19e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—coronary artery disease	2.43e-06	1.12e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	2.4e-06	1.1e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—coronary artery disease	2.23e-06	1.02e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	2.21e-06	1.01e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK1—coronary artery disease	2.19e-06	1e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	2.16e-06	9.92e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CA—coronary artery disease	1.9e-06	8.72e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	1.88e-06	8.6e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—coronary artery disease	1.68e-06	7.72e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—coronary artery disease	1.66e-06	7.62e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT1—coronary artery disease	1.55e-06	7.12e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT1—coronary artery disease	1.53e-06	7.03e-06	CbGpPWpGaD
